Zou Jiupeng, Shu Mi, Chen Jiedong, Wusiman Maierhaba, Ye Jialu, Yang Sishi, Chen Si, Huang Zihui, Huang Bixia, Fang Aiping, Zhu Huilian
Guangdong Provincial Key Laboratory of Food, Nutrition and Health, School of Public Health, Sun Yat-sen University, Guangzhou 510080, China.
Guangzhou Shiyuan Health Management Company Limited, Guangzhou 510000, China.
Nutrients. 2025 Jan 6;17(1):192. doi: 10.3390/nu17010192.
This research investigated the prospective association of serum homocysteine with lumbar bone mineral density (BMD) and the risk of osteoporosis in the Chinese population.
In this cohort, 2551 Chinese individuals aged ≥50 years underwent annual health examinations. Among them, 2551, 1549, and 926 completed two, three, and more than three examinations, respectively. We used generalized estimating equations to analyze the connection between serum homocysteine and lumbar BMD. Additionally, we assessed the connection between serum homocysteine and the incidence of osteoporosis using Cox proportional hazard models. Subgroup analyses based on covariates were performed to identify important at-risk populations.
Participants with higher homocysteine levels showed decreased lumbar BMD compared to those with lower homocysteine levels (-trend < 0.05). Specifically, lumbar BMD decreased by -0.002 (-0.003, -0.001) g/cm for every standard deviation increase in log-transformed serum homocysteine. Compared to the lowest quartile of homocysteine levels, lumbar BMD decreased by -0.006 (-0.010, -0.002) g/cm in the highest quartile in men. In smokers, lumbar BMD decreased by -0.007 (-0.012, -0.003) g/cm in the highest quartile. During the follow-up period, 175 incidences of osteoporosis were recorded. Serum homocysteine was linked to an increased risk of osteoporosis (-trend < 0.05). Furthermore, for every standard deviation rise in log-transformed homocysteine, the HR for osteoporosis was 1.33 (95% CI, 1.12-1.58).
Elevated homocysteine levels may be responsible for reduced lumbar BMD in middle-aged and older Chinese people, especially men and smokers. In addition, elevated homocysteine levels may be a risk factor for the development of osteoporosis.
本研究调查了中国人群中血清同型半胱氨酸与腰椎骨密度(BMD)的前瞻性关联以及骨质疏松症的风险。
在该队列中,2551名年龄≥50岁的中国人接受了年度健康检查。其中,分别有2551人、1549人和926人完成了两次、三次及三次以上检查。我们使用广义估计方程分析血清同型半胱氨酸与腰椎骨密度之间的联系。此外,我们使用Cox比例风险模型评估血清同型半胱氨酸与骨质疏松症发病率之间的联系。基于协变量进行亚组分析以识别重要的高危人群。
与同型半胱氨酸水平较低的参与者相比,同型半胱氨酸水平较高的参与者腰椎骨密度降低(-趋势<0.05)。具体而言,对数转换后的血清同型半胱氨酸每增加一个标准差,腰椎骨密度降低-0.002(-0.003,-0.001)g/cm。与同型半胱氨酸水平最低的四分位数相比,男性中同型半胱氨酸水平最高的四分位数中腰椎骨密度降低-0.006(-0.010,-0.002)g/cm。在吸烟者中,同型半胱氨酸水平最高的四分位数中腰椎骨密度降低-0.007(-0.012,-0.003)g/cm。在随访期间,记录到175例骨质疏松症病例。血清同型半胱氨酸与骨质疏松症风险增加有关(-趋势<0.05)。此外,对数转换后的同型半胱氨酸每增加一个标准差,骨质疏松症的风险比(HR)为1.33(95%置信区间,1.12-1.58)。
同型半胱氨酸水平升高可能导致中国中老年人,尤其是男性和吸烟者腰椎骨密度降低。此外,同型半胱氨酸水平升高可能是骨质疏松症发生的一个危险因素。